Brain Ischemia in Alzheimer's Disease May Partly Counteract the Disruption of the Blood-Brain Barrier

被引:0
|
作者
Bateman, Grant A. [1 ,2 ]
Bateman, Alexander R. [3 ]
机构
[1] John Hunter Hosp, Dept Med Imaging, Newcastle, NSW 2310, Australia
[2] Newcastle Univ, Coll Hlth Med & Wellbeing, Sch Med & Publ Hlth, Callaghan Campus, Newcastle, NSW 2308, Australia
[3] Newcastle Univ, Coll Engn Sci & Environm, Sch Engn, Callaghan Campus, Newcastle, NSW 2308, Australia
关键词
Alzheimer's disease; blood-brain barrier; cerebral blood flow; CSF formation rate; glymphatic; ischemia; normal pressure hydrocephalus; NORMAL-PRESSURE HYDROCEPHALUS; MILD COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; CEREBRAL PERFUSION; VENOUS-PRESSURE; FLOW; PATHOGENESIS; METABOLISM; PHYSIOLOGY; HUMANS;
D O I
10.3390/brainsci15030269
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: In normal pressure hydrocephalus (NPH) there is blood-brain barrier (BBB) disruption, which should increase the CSF formation rate (CSFfr) and, therefore, also increase the intracranial pressure (ICP). However, the ICP is normal in NPH. A lumped parameter study was performed to look at the interrelation between the ICP, cerebral blood flow (CBF), and the degree of BBB disruption in NPH. The model suggested that the CSFfr could be reduced in this condition if the BBB disruption was moderated by a reduction in the capillary transmural pressure (TMP) secondary to arteriolar constriction and a reduced CBF. In early Alzheimer's disease (AD), there is BBB disruption, reduced ICP, and global ischemia. This raises the possibility that the same physiology may occur in AD as occurs in NPH. Methods: A lumped parameter model previously used to describe the hydrodynamics of NPH was modified to investigate the effects of changes in CSF pressure and blood flow in patients with mild cognitive impairment (MCI) and AD. Results: The model indicates that the average capillary TMP is normal in MCI, but decreases as AD progresses. Removing CSF in AD patients during a tap test initially increases the capillary TMP. The brain in AD responds to a tap test by increasing its level of ischemia, and this reduces the capillary TMP. Conclusions: A hypothesis is put forward that the BBB disruption in AD is partially mitigated by the brain making itself ischemic. Modelling gives support to this hypothesis. The model can suggest a cause for the development of ischemic neuronal loss and amyloid accumulation secondary to glymphatic flow disruption as AD progresses.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] The blood-brain barrier in Alzheimer's disease
    Zenaro, Elena
    Piacentino, Gennj
    Constantin, Gabriela
    NEUROBIOLOGY OF DISEASE, 2017, 107 : 41 - 56
  • [2] Role of Blood-Brain Barrier in Alzheimer's Disease
    Cai, Zhiyou
    Qiao, Pei-Feng
    Wan, Cheng-Qun
    Cai, Min
    Zhou, Nan-Kai
    Li, Qin
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (04) : 1223 - 1234
  • [3] The integrity of the blood-brain barrier in Alzheimer's disease
    Algotsson, A.
    Winblad, B.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (06): : 403 - 408
  • [4] Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
    Bell, Robert D.
    Zlokovic, Berislav V.
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 103 - 113
  • [5] Drug delivery to the brain in Alzheimer's disease: Consideration of the blood-brain barrier
    Banks, William A.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (07) : 629 - 639
  • [6] Deficiency in Mural Vascular Cells Coincides with Blood-Brain Barrier Disruption in Alzheimer's Disease
    Sengillo, Jesse D.
    Winkler, Ethan A.
    Walker, Corey T.
    Sullivan, John S.
    Johnson, Mahlon
    Zlokovic, Berislav V.
    BRAIN PATHOLOGY, 2013, 23 (03) : 303 - 310
  • [7] Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease
    Huang, Zhangsen
    Wong, Lik-Wei
    Su, Yixun
    Huang, Xiaomin
    Wang, Nan
    Chen, Hui
    Yi, Chenju
    FRONTIERS IN NEUROENDOCRINOLOGY, 2020, 59
  • [8] Addressing Blood-Brain Barrier Impairment in Alzheimer's Disease
    Sharma, Chanchal
    Woo, Hanwoong
    Kim, Sang Ryong
    BIOMEDICINES, 2022, 10 (04)
  • [9] Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links
    He, Jin-Ting
    Zhao, Xin
    Xu, Lei
    Mao, Cui-Ying
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (01) : 39 - 58
  • [10] Blood-brain barrier P-glycoprotein function in Alzheimer's disease
    van Assema, Danielle M. E.
    Lubberink, Mark
    Bauer, Martin
    van der Flier, Wiesje M.
    Schuit, Robert C.
    Windhorst, Albert D.
    Comans, Emile F. I.
    Hoetjes, Nikie J.
    Tolboom, Nelleke
    Langer, Oliver
    Mueller, Markus
    Scheltens, Philip
    Lammertsma, Adriaan A.
    van Berckel, Bart N. M.
    BRAIN, 2012, 135 : 181 - 189